Table 1 Overall baseline characteristics according to IL-6 group
Overall | IL-6 ≤ 0.45 | IL-6 > 0.45 | p | |
|---|---|---|---|---|
n | 100 | 32 | 68 | |
Age (years) | 61.1 (8.7) | 58.4 (7.1) | 62.8 (9.2) | |
Male | 44 (44.0) | 11 (34.4) | 34 (50.0) | 0.196 |
BMI (kg/m2) | 28.7(5.6) | 27.1 (5.4) | 29.5 (5.6) | 0.053 |
AC (cm) | 100.7 (14.3) | 95.7 (12.1) | 103.1 (14.7) | 0.015 |
SBP (mmHg) | 140(22) | 136.4 (20.7) | 142.1(23.2) | 0.236 |
DBP (mmHg) | 76.9 (12.6) | 75.1 (10.40) | 77.8 (13.5) | 0.328 |
% of hypertension | 85 (85.0) | 22(68.8) | 63 (92.6) | 0.005 |
CAD > 30% | 81 (81.0) | 23 (71.9) | 58 (85.3) | 0.170 |
n of T2DM (%) | 61 (61.0) | 10 (31.3) | 51 (75.0) | < 0.001 |
n of current smoking (%) | 20 (20.0) | 5(15.6) | 15(22.1) | 0.595 |
n with decreased eGFR (%) | 45 (45.0) | 11 (34.4) | 34 (50.0) | 0.196 |
n with previous AMI (%) | 28 (28.0) | 6 (19.4) | 22(32.8) | 0.231 |
n with heart failure (%) | 17 (17.0) | 2 (18.2) | 15 (29.4) | 0.712 |
HbA1c (%) | 6.8 (1.50) | 6.3 (1.4) | 7.1 (1.5) | 0.02 |
Blood glucose (mg/dL) | 112 (92–154) | 97 (88 – 127) | 117 (99 – 164) | 0.016 |
Total cholesterol (mg/dL) | 163 (133.5–194.5) | 179 (134–200) | 158 (132 – 182) | 0.075 |
Serum creatinine (mg/dL) | 0.82 (0.2) | 0.72 (1.5) | 0.86 (0.2) | 0.001 |
IL-6 (pg/mL) | 1.10 (1.6–2.10) | 0.09 (0.04–0.14) | 1.5(0.96–2.40) | < 0.001 |
hs-CRP | 2.6 (1.2 -7.9) | 1.63 (1.0 -2.8) | 3.9 (1.5–8.7) | 0.008 |
% Using aspirin | 71.0 | 67..7 | 74.6 | 0.478 |
% Using clopidogrel | 16.0 | 27.3 | 25.5 | 1.000 |
% Using ACEi | 35.0 | 54.5 | 56.9 | 1.000 |
% Using ARB | 19.0 | 18.2 | 33.3 | 0.478 |
% Using beta blockers | 48.0 | 72.7 | 78.4 | 0.700 |
% Using statins | 83.0 | 80.6 | 86.6 | 0.548 |